AptaBio Therapeutics Statistics

Total Valuation

KOSDAQ:293780 has a market cap or net worth of KRW 210.48 billion. The enterprise value is 193.53 billion.

Market Cap	210.48B
Enterprise Value	193.53B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:293780 has 26.88 million shares outstanding. The number of shares has increased by 6.87% in one year.

Current Share Class	26.88M
Shares Outstanding	26.88M
Shares Change (YoY)	+6.87%
Shares Change (QoQ)	-3.65%
Owned by Insiders (%)	28.45%
Owned by Institutions (%)	3.00%
Float	18.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	67.76
PB Ratio	4.07
P/TBV Ratio	4.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.91
EV / Sales	62.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.71

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.15.

Current Ratio	1.79
Quick Ratio	1.59
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	-0.48
Interest Coverage	-6.79

Financial Efficiency

Return on equity (ROE) is -51.24% and return on invested capital (ROIC) is -19.16%.

Return on Equity (ROE)	-51.24%
Return on Assets (ROA)	-15.63%
Return on Invested Capital (ROIC)	-19.16%
Return on Capital Employed (ROCE)	-36.44%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.04
Inventory Turnover	26.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.34% in the last 52 weeks. The beta is 1.61, so KOSDAQ:293780's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	+38.34%
50-Day Moving Average	7,362.60
200-Day Moving Average	7,593.50
Relative Strength Index (RSI)	55.18
Average Volume (20 Days)	69,332

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:293780 had revenue of KRW 3.11 billion and -27.99 billion in losses. Loss per share was -1,161.66.

Revenue	3.11B
Gross Profit	220.53M
Operating Income	-20.24B
Pretax Income	-26.42B
Net Income	-27.99B
EBITDA	-19.70B
EBIT	-20.24B
Loss Per Share	-1,161.66

Full Income Statement

Balance Sheet

The company has 24.93 billion in cash and 7.97 billion in debt, giving a net cash position of 16.96 billion or 630.76 per share.

Cash & Cash Equivalents	24.93B
Total Debt	7.97B
Net Cash	16.96B
Net Cash Per Share	630.76
Equity (Book Value)	51.73B
Book Value Per Share	1,924.47
Working Capital	13.02B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.25 billion and capital expenditures -277.03 million, giving a free cash flow of -16.53 billion.

Operating Cash Flow	-16.25B
Capital Expenditures	-277.03M
Free Cash Flow	-16.53B
FCF Per Share	-614.80

Full Cash Flow Statement

Margins

Gross Margin	7.10%
Operating Margin	-651.42%
Pretax Margin	-850.35%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:293780 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.87%
Shareholder Yield	n/a
Earnings Yield	-13.30%
FCF Yield	-7.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 24, 2021. It was a forward split with a ratio of 2.

Last Split Date	Aug 24, 2021
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:293780 has an Altman Z-Score of 2.8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.8
Piotroski F-Score	n/a